Skip to Main Content

Paper Details

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study.
Ann Surg Open
5
2022
Pan-NET, Pancreatic Neuroendocrine Tumors, Patients, SG, metastatic disease, pancreatic neuroendocrine tumors, patients, tumor
Author NameAffiliation
Jennifer A ChanDana-Farber Cancer Institute
Jennifer A ChanDana-Farber Cancer Institute
  • 1 - 2

Datasets

Release 1.2